1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Nigeria Pharmaceuticals and Healthcare Report Q1 2015

Nigeria Pharmaceuticals and Healthcare Report Q1 2015

  • November 2014
  • -
  • Business Monitor International
  • -
  • 116 pages

Includes 3 FREE quarterly updates

BMI View:
The Nigerian government remains committed to improving healthcare quality and infrastructure across the country. The formation of the National Health Insurance Scheme (NHIS) has seen a growing number of citizens enrolled since its formation in 2005, albeit lower than previously anticipated. We believe Nigeria's pharmaceutical market has the capacity for considerable future growth in the long term due to its increasing population and high burden of disease. Despite this, scant healthcare funding, weak patent protection and low per capita spending will continue to impede the market's potential.

Headline Expenditure Projections

- Pharmaceuticals: NGN203.66bn (USD1.28bn) in 2013 to NGN234.71bn (USD1.44bn) in 2014; +15.2% in local currency terms and +12.8% in US dollar terms. Forecast revised down from last quarter to better suit current market conditions.
- Healthcare: NGN2,792.53bn (USD17.54bn) in 2013 to NGN3,091.82bn (USD19.01bn) in 2014; +10.7% in local currency terms and +8.4% in US dollar terms.

Table Of Contents

Nigeria Pharmaceuticals and Healthcare Report Q1 2015
BMI Industry View 7
SWOT 9
Political 12
Economic 13
Business Environment 14
Industry Forecast 15
Pharmaceutical Market Forecast 15
Table: Pharmaceutical Sales, Historical Data And Forecasts (Nigeria 2010-2018) 16
Healthcare Market Forecast 17
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2010-2018) 18
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2010-2018) 19
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Nigeria 2010-2018) 19
Prescription Drug Market Forecast 20
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Nigeria 2010-2018) 21
Patented Drug Market Forecast 22
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Nigeria 2010-2018) 23
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Nigeria 2010-2018) 24
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Nigeria 2010-2018) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Nigeria 2012-2018) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Nigeria 2012-2018) 29
Other Healthcare Data 29
Key Risks To BMI's Forecast Scenario 30
Macroeconomic Forecasts 32
Nigeria- Security Issues To Weigh On Northern Consumption 32
Table: Economic Activity (Nigeria 2009-2018) 37
Industry Risk Reward Ratings 38
Middle East and Africa Risk/Reward Index 38
Nigeria Risk/Reward Ratings 45
Rewards 45
Risks 46
Market Overview 47
Industry Trends And Developments 48
Epidemiology 48
Maternal And Child Health 49
Non-Communicable Diseases 50
Communicable Disease 50
Healthcare Sector 52
Healthcare Sector Developments 52
Healthcare Financing 53
Healthcare Provision 54
Health Insurance 56
Traditional Medicine 58
Telemedicine 59
Research and Development 60
Clinical Trials 60
Regulatory Development 62
Regulatory Regime 62
Domestic Drugmakers 63
Intellectual Property Regime 63
Pricing And Reimbursement Regime 66
National Drug Policy 67
Medical Tourism 67
Competitive Landscape 69
Domestic Industry 70
Foreign Industry 72
Pharmaceutical Distribution 74
Company Profile 77
Nigerian-German Chemicals (NGC) 77
Emzor Pharmaceutical Industries 80
Fidson Healthcare 82
May and Baker 85
Neros Pharmaceuticals 87
Drugfield Pharmaceuticals 89
Neimeth Pharmaceuticals 91
Pfizer 94
Novartis 97
Sanofi 99
Merck and Co 101
GlaxoSmithKline 103
Demographic Forecast 106
Demographic Outlook 106
Table: Nigeria's Population By Age Group, 1990-2020 ('000) 107
Table: Nigeria's Population By Age Group, 1990-2020 (% of total) 108
Table: Nigeria's Key Population Ratios, 1990-2020 109
Table: Nigeria's Rural And Urban Population, 1990-2020 109
Glossary 110
Methodology 112
Pharmaceutical Expenditure Forecast Model 112
Healthcare Expenditure Forecast Model 112
Notes On Methodology 113
Risk/Reward Index Methodology 114
Index Overview 115
Table: Pharmaceutical Risk/Reward Index Indicators 115
Indicator Weightings 116

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7 000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

IMS World Review Executive™ 2016

IMS World Review Executive™ 2016

  • $ 6 860
  • Industry report
  • July 2016
  • by IMS Health

IMS World Review ExecutiveTM 2016 provides essential insights into worldwide sales of the pharmaceutical market, interlocking market trends and sales analysis from 2011 to 2015, including the breakdown ...


Download Unlimited Documents from Trusted Public Sources

Generic Drug Industry in the US

  • September 2016
    9 pages
  • Generic Drug  

  • United States  

View report >

Opioid and Therapy Market in the US

  • September 2016
    11 pages
  • Opioid  

    Therapy  

    Analgesic  

  • United States  

View report >

Opioid Market in the US

  • September 2016
    13 pages
  • Opioid  

    Anesthetics  

    Analgesic  

  • United States  

View report >

Related Market Segments :

Pharmaceutical
Healthcare

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.